Scilex Holding Co

Vickers Vantage Corp. I (Nasdaq: VCKA), a blank-check company that completed its initial public offering in 2021 under the sponsorship of Vickers Capital Management, filed an 8-K with the SEC on March 21, 2022, disclosing a material development related to its proposed business combination with Scilex Holding Company, a specialty pharmaceutical firm focused on non-opioid pain management and a subsidiary of Sorrento Therapeutics. The SPAC targeted the healthcare and life sciences sector. The filing, bearing accession number 0001213900-22-013697, is part of the ongoing regulatory record for the de-SPAC transaction between VCKA and Scilex. Sign up for a SpacDesk account to access the full filing history, deal timeline, and analytics for VCKA and hundreds of other SPAC transactions.